UnitedHealth Group
Market Cap
US$220.7b
Last Updated
2019/09/22 23:40 UTC
Data Sources
Company Financials +
Executive Summary
UnitedHealth Group Incorporated operates as a diversified health care company in the United States.
Snowflake
Fundamentals
Solid track record established dividend payer.
Similar Companies
Share Price & News
How has UnitedHealth Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-0.3%
UNH
-0.3%
US Healthcare
-0.6%
US Market
1 Year Return
-12.7%
UNH
-9.2%
US Healthcare
0.7%
US Market
UNH underperformed the Healthcare industry which returned -9.1% over the past year.
UNH underperformed the Market in United States of America which returned 0.7% over the past year.
Share holder returns
| UNH | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.3% | -0.3% | -0.6% |
| 30 Day | 1.0% | 2.1% | 4.9% |
| 90 Day | -6.7% | -0.8% | 1.7% |
| 1 Year | -11.2%-12.7% | -7.8%-9.2% | 3.0%0.7% |
| 3 Year | 73.4%65.7% | 29.7%24.4% | 44.8%35.4% |
| 5 Year | 190.9%168.9% | 66.1%56.2% | 62.0%44.3% |
Price Volatility Vs. Market
How volatile is UnitedHealth Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
UnitedHealth Group (NYSE:UNH) Has A Pretty Healthy Balance Sheet2 weeks ago | Simply Wall St
UnitedHealth Group Incorporated (NYSE:UNH) Looks Like A Good Stock, And It's Going Ex-Dividend Soon2 weeks ago | Simply Wall St
Do UnitedHealth Group's (NYSE:UNH) Earnings Warrant Your Attention?Valuation
Is UnitedHealth Group undervalued based on future cash flows and its price relative to the stock market?
>50%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
UnitedHealth Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
UnitedHealth Group's share price is below the future cash flow value, and at a substantial discount (> 40%).
Price Based on Earnings
UnitedHealth Group is good value based on earnings compared to the US Healthcare industry average.
UnitedHealth Group is good value based on earnings compared to the United States of America market.
Price Based on Expected Growth
UnitedHealth Group is poor value based on expected growth next year.
Price Based on Value of Assets
UnitedHealth Group is overvalued based on assets compared to the US Healthcare industry average.
Next Steps
Future Growth
How is UnitedHealth Group expected to perform in the next 1 to 3 years based on estimates from 17 analysts?
11.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
UnitedHealth Group's revenue is expected to grow by 6.3% yearly, however this is not considered high growth (20% yearly).
UnitedHealth Group's earnings are expected to grow by 11.2% yearly, however this is not considered high growth (20% yearly).
UnitedHealth Group's revenue growth is positive but not above the United States of America market average.
UnitedHealth Group's earnings growth is positive but not above the United States of America market average.
UnitedHealth Group's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
UnitedHealth Group is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
Next Steps
Past Performance
How has UnitedHealth Group performed over the past 5 years?
20.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
UnitedHealth Group has delivered over 20% year on year earnings growth in the past 5 years.
UnitedHealth Group's 1-year earnings growth is less than its 5-year average (9.5% vs 20.5%)
UnitedHealth Group's earnings growth has exceeded the US Healthcare industry average in the past year (9.5% vs 5.6%).
Return on Equity
UnitedHealth Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
Return on Assets
UnitedHealth Group used its assets more efficiently than the US Healthcare industry average last year based on Return on Assets.
Return on Capital Employed
UnitedHealth Group has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is UnitedHealth Group's financial position?
Financial Position Analysis
UnitedHealth Group's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
UnitedHealth Group's long term commitments exceed its cash and other short term assets.
Debt to Equity History and Analysis
UnitedHealth Group's level of debt (72.8%) compared to net worth is high (greater than 40%).
The level of debt compared to net worth has increased over the past 5 years (49% vs 72.8% today).
Debt is well covered by operating cash flow (29.4%, greater than 20% of total debt).
Interest payments on debt are well covered by earnings (EBIT is 12.1x coverage).
Balance Sheet
Low level of unsold assets.
Debt is not covered by short term assets, assets are 0.9x debt.
Next Steps
Dividend
What is UnitedHealth Group's current dividend yield, its reliability and sustainability?
1.96%
Expected Dividend Yield
Dividend Yield and Payments Analysis
UnitedHealth Group's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
UnitedHealth Group's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).
Dividends per share have been stable in the past 10 years.
Dividends per share have increased over the past 10 years.
Current Payout to Shareholders
Dividends paid are well covered by earnings (3.6x coverage).
Future Payout to Shareholders
Dividends after 3 years are expected to be well covered by earnings (4.3x coverage).
Next Steps
Management
What is the CEO of UnitedHealth Group's salary, the management and board of directors tenure and is there insider trading?
2.0yrs
Average management tenure
CEO
Dave Wichmann (56yo)
2yrs
Tenure
US$18,107,356
Compensation
Mr. David Scott Wichmann, also known as Dave, serves as a Director of Surgical Care Affiliates, Inc. Mr. Wichmann has been the Chief Executive Officer and Director of UnitedHealth Group Incorporated since ...
CEO Compensation Analysis
Dave's remuneration is higher than average for companies of similar size in United States of America.
Dave's compensation has been consistent with company performance over the past year, both up more than 20%.
Management Age and Tenure
2.0yrs
Average Tenure
57yo
Average Age
The tenure for the UnitedHealth Group management team is about average.
Board Age and Tenure
2.4yrs
Average Tenure
65yo
Average Age
The average tenure for the UnitedHealth Group board of directors is less than 3 years, this suggests a new board.
Insider Trading
UnitedHealth Group individual insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 5,000 |
| Max Price | US$232.76 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 2,000 |
| Max Price | US$227.55 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 2,000 |
| Max Price | US$231.50 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 5,000 |
| Max Price | US$246.40 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 12,000 |
| Max Price | US$255.31 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 10,000 |
| Max Price | US$248.00 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 10,000 |
| Max Price | US$241.99 |
| Entity | Individual |
| Role | Chief Executive Officer CEO & Director |
| Shares | 20,000 |
| Max Price | US$231.79 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 6,430 |
| Max Price | US$233.21 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 10,000 |
| Max Price | US$229.75 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 5,000 |
| Max Price | US$257.32 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 5,000 |
| Max Price | US$245.01 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 11,500 |
| Max Price | US$268.00 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 15,000 |
| Max Price | US$260.55 |
| Entity | Individual |
| Role | Lead Director Lead Independent Director |
| Shares | 6,090 |
| Max Price | US$281.72 |
| Entity | Individual |
| Shares | 163 |
| Max Price | US$274.83 |
Ownership Breakdown
Management Team
Steve Hemsley (66yo)
Executive Chairman of the Board
- Tenure: 2yrs
- Compensation: US$11.35m
Larry Renfro (65yo)
Office of the Chief Executive & Vice Chairman
- Tenure: 4.8yrs
- Compensation: US$14.24m
Richard Burke (76yo)
Lead Independent Director
- Tenure: 2yrs
- Compensation: US$405.99k
Andrew Witty (54yo)
Executive VP & Member of Office of the Chief Executive
- Tenure: 1.7yrs
- Compensation: US$22.00m
Steve Nelson (60yo)
Executive VP & Office of the Chief Executive
- Tenure: 2yrs
- Compensation: US$9.76m
Dave Wichmann (56yo)
CEO & Director
- Tenure: 2yrs
- Compensation: US$18.11m
John Rex (57yo)
CFO, Executive VP & Member of the Office of the Chief Executive
- Tenure: 3.3yrs
- Compensation: US$8.59m
Phil McKoy (46yo)
Chief Information Officer
- Tenure: 0yrs
Tom Roos (46yo)
Senior VP & Chief Accounting Officer
- Tenure: 4.1yrs
Ken Ehlert
Chief Scientific Officer & Member of Office of the Chief Executive
- Tenure: 0.7yrs
Board Members
Glenn Renwick (64yo)
Director
- Tenure: 18.7yrs
- Compensation: US$352.72k
Steve Hemsley (66yo)
Executive Chairman of the Board
- Tenure: 2yrs
- Compensation: US$11.35m
Michele Hooper (67yo)
Director
- Tenure: 11.9yrs
- Compensation: US$338.71k
Bill Ballard (78yo)
Director
- Tenure: 26.7yrs
- Compensation: US$325.31k
Richard Burke (76yo)
Lead Independent Director
- Tenure: 2yrs
- Compensation: US$405.99k
Gail Wilensky (76yo)
Director
- Tenure: 26.7yrs
- Compensation: US$338.60k
Tim Flynn (62yo)
Director
- Tenure: 2.7yrs
- Compensation: US$325.55k
Dave Wichmann (56yo)
CEO & Director
- Tenure: 2yrs
- Compensation: US$18.11m
Bill McNabb (62yo)
Director
- Tenure: 1.6yrs
- Compensation: US$189.63k
Valerie C. Rice (57yo)
Director
- Tenure: 2.1yrs
- Compensation: US$318.33k
Company Information
UnitedHealth Group Incorporated's company bio, employee growth, exchange listings and data sources
Key Information
- Name: UnitedHealth Group Incorporated
- Ticker: UNH
- Exchange: NYSE
- Founded: 1977
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$220.705b
- Shares outstanding: 947.68m
- Website: https://www.unitedhealthgroup.com
Number of Employees
Location
- UnitedHealth Group Incorporated
- UnitedHealth Group Center
- 9900 Bren Road East
- Minnetonka
- Minnesota
- 55343
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| UNH | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Oct 1984 |
| UNH | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Oct 1984 |
| UNH * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Oct 1984 |
| UNH | SNSE (Santiago Stock Exchange) | Yes | Common Stock | CL | USD | Oct 1984 |
| UNH | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Oct 1984 |
| 0R0O | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Oct 1984 |
| UNH | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Oct 1984 |
| UNHH34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 1 REP 0.2 COM USD0.01 | BR | BRL | May 2019 |
Biography
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHe ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/22 23:40 |
| End of Day Share Price | 2019/09/20 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.